Jeena Sikho Lifecare Limited expanded its healthcare and wellness portfolio by launching Amrit Dhara Drops 20 ml on August 4, 2026. The new Ayurvedic product is designed for the domestic market and focuses on managing cold and cough symptoms using traditionally used herbs. This launch reinforces the company’s presence in the herbal remedies segment, adding to its existing network of over 120 Ayurveda clinics and hospitals.

The company disclosed the launch under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The information was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Product Details

The key specifications of the newly launched product are outlined below:

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, signed the intimation filed with the stock exchanges. The company operates from its registered office in Zirakpur, Punjab, and its corporate office in New Multan Nagar, Delhi.

Strategic Context

The introduction of Amrit Dhara Drops aligns with Jeena Sikho Lifecare’s broader strategy to offer drug-free solutions for common ailments. By targeting the domestic market with a specialized formulation for cold and cough, the company aims to deepen its penetration in the consumer-facing Ayurvedic sector. The product packaging highlights traditional herbs, emphasizing the natural composition of the drops.

This expansion adds a new SKU to the company’s offerings without entering international markets at this stage. The focus remains on leveraging the company’s extensive clinic network to drive awareness and sales within India.

Jeena Sikho Lifecare will host an earnings conference call for investors and analysts on Monday, August 10, 2026, at 12:00 PM IST. The event is scheduled to discuss the company’s unaudited financial results for the first quarter of fiscal year 2027 (Q1FY27), covering the period ended June 30, 2026. This engagement follows the Board of Directors’ meeting held to announce these standalone and consolidated results, providing stakeholders with direct access to management commentary on performance metrics and operational updates.

The conference call is being conducted in compliance with Regulation 30(6) read with Schedule III Part A Para A Clause 15 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jeena Sikho Lifecare submitted the intimation to the National Stock Exchange of India Limited (NSE) and BSE Limited on August 4, 2026. The filing confirms that the audio/video recording and transcript of the conference call will be made available on the company’s website in due course.

Key Participants and Logistics

The earnings call will be hosted by Go India Advisors. Key company executives participating in the discussion include Manish Grover, Managing Director, and Nanak Chand, Chief Financial Officer. Investors and analysts are required to pre-register to receive login details for the virtual event.

Accessing the Conference Call

Participants must pre-register via the provided link to obtain necessary login credentials. The universal dial-in numbers for the event are +91 22 6280 1557 and +91 22 7115 8383. For further assistance or registration support, investors may contact Go India Advisors representatives Sheetal Khanduja, Soumya Chhajer, or Shrutee Barve using the contact details provided in the official flyer.

What the Numbers Show

While specific financial figures for Q1FY27 were not detailed in this intimation notice, the scheduling of this dedicated investor dialogue underscores the company’s commitment to transparency following its quarterly reporting cycle. The focus of the upcoming call will likely center on revenue trends, profitability metrics, and strategic initiatives within the Ayurveda clinics and hospitals segment, which operates over 120 locations. Stakeholders should monitor the company’s website for the post-call transcript and recording for deeper insights into the quarter’s performance drivers.